🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

75,69 EUR

Máx. histórico

110,88

546 días

Caída desde máximo

-31,74%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,75%

Cierre anterior

76,26

Rango de hoy

75,22 – 76,19

Volumen hoy

910.041

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,36 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 11 horas
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,44%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/09/2013 72,95 74,07 72,82 74,00 +2,35% 1,70% 1.809.563
30/08/2013 74,10 74,33 72,30 72,30 -2,03% 2,75% 3.461.263
29/08/2013 73,63 73,99 73,04 73,80 +0,95% 1,28% 2.351.557
28/08/2013 74,14 74,66 73,10 73,10 -2,00% 2,11% 4.625.398
27/08/2013 76,21 76,21 74,59 74,59 -2,15% 2,13% 3.557.668
26/08/2013 74,83 76,57 74,83 76,23 +2,28% 2,33% 1.676.913
23/08/2013 74,87 74,94 74,04 74,53 -0,94% 1,21% 3.085.753
22/08/2013 75,25 76,04 75,03 75,24 -0,13% 1,35% 3.398.933
21/08/2013 76,96 77,13 75,34 75,34 -1,55% 2,33% 2.513.617
20/08/2013 77,05 77,44 76,46 76,52 -0,59% 1,27% 2.635.856
19/08/2013 77,33 77,49 76,61 76,98 -0,45% 1,13% 1.788.283
16/08/2013 77,08 77,56 76,71 77,33 +0,53% 1,10% 2.462.110
15/08/2013 77,75 77,79 76,24 76,92 -0,88% 1,98% 2.432.681
14/08/2013 78,06 78,10 77,28 77,61 -0,27% 1,06% 2.074.760
13/08/2013 77,46 77,81 77,11 77,81 +0,70% 0,91% 1.913.892
12/08/2013 77,68 77,97 76,97 77,28 -1,46% 1,29% 2.344.299
09/08/2013 78,42 78,69 78,07 78,42 +0,15% 0,79% 2.093.445
08/08/2013 77,93 78,81 77,68 78,30 +0,52% 1,45% 2.420.701
07/08/2013 77,97 78,77 77,55 77,89 +1,06% 1,57% 2.993.626
06/08/2013 76,78 77,95 76,68 77,08 +1,03% 1,66% 3.153.865
05/08/2013 76,11 76,43 75,72 76,29 +0,46% 0,94% 2.177.794
02/08/2013 76,83 77,08 75,64 75,95 -0,64% 1,88% 3.325.995
01/08/2013 75,34 76,68 74,39 76,43 -4,14% 3,04% 7.312.423
31/07/2013 78,57 80,27 78,42 79,73 +0,11% 2,35% 3.146.585
30/07/2013 79,26 80,10 79,12 79,64 +0,58% 1,24% 1.775.980
29/07/2013 79,25 79,85 78,97 79,19 -0,04% 1,12% 1.600.129
26/07/2013 79,21 79,70 79,03 79,22 +0,31% 0,85% 1.423.741
25/07/2013 79,46 79,89 78,31 78,97 -0,44% 1,99% 1.864.692
24/07/2013 79,17 80,40 78,93 79,32 +0,21% 1,86% 2.049.122
23/07/2013 80,16 80,16 79,15 79,15 -0,85% 1,27% 1.682.369